Comparative efficacy of ibrutinib versus other covalent Bruton tyrosine kinase inhibitors (cBTKis) in first-line (1L) chronic lymphocytic leukemia (CLL): A matched-adjusted indirect comparison (MAIC).

Authors: Alexey Valeryevich Danilov, Mazyar Shadman, Jan Andreas Burger, Adam Kittai, Susan Mary O'Brien, Constantine Si Lun Tam, Matthew Schulz, Gabe Krigsfeld, Hsin-Hui Huang, Deborah M. Stephens, Talha Munir

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19023

Source: Full article

---

Abstract

e19023